ReShape vBloc Clinical Studies

Clinical data on ReShape vBloc demonstrates significant weight loss for patients.

Intermittent Vagal Nerve Block for Improvements in Obesity, Cardiovascular Risk Factors, and Glycemic Control in Patients with Type 2 Diabetes Mellitus: 2-Year Results of the VBLOC DM2 Study

Publisher: Obes Surg. 2015; DOI:10.1007/s11695-015-1914-1.

Author: Shikora | Date: 2015

download study

Reversible Vagal Nerve Blocking (VBLOC) in Patients with Moderate Obesity and an Obesity Related Co-morbid Condition: The ReCharge Study

Publisher: IFSO Conference 2015, 26-29th August 2015, Vienna, Austria.

Author: Shikora | Date: 2015

download study

Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial

Publisher: J Obes. 2015;2015:365604. DOI:10.1155/2015/365604.

Author: Shikora | Date: 2015

download study

Midterm Results of Reversible Vagal Nerve Blocking (VBLOC) in Obese Patients Suffering from Type 2 Diabetes Mellitus (T2DM): The DM2 Study

Publisher: Obes Surg. 2014;24(8):1148-1149.

Author: Shikora | Date: 2014

download study

The EMPOWER Study: Randomized, Prospective, Double-Blind, Multicenter Trial of Vagal Blockage to Induce Weight Loss in Morbid Obesity

Publisher: Obes Surg. 2012;22(11):1771-1782. doi:10.1007/s11695-012-0751-8.

Author: Sarr | Date: 2012

download study

Vagal Blocking: Treatment of Obesity Related Type 2 Diabetes and Blood Pressure – 18 Month Results

Publisher: IFSO-EC Conference 2012, 24-29th April 2012, Barcelona, Spain.

Author: Toouli | Date: 2012

download study

Reduced Calorie Intake and Weight Loss During Vagal Blocking in Subjects with Obesity-Related Type 2 Diabetes Mellitus

Publisher: Obesity. 2011;19:S190.

Author: Wray | Date: 2011

download study

Vagal Blocking for the Treatment of Obesity Delivered Using the Fully Implantable Maestro Rechargeable System: 12 Month Results

Publisher: Surg Obes Relat Dis. 2011;7:363-364.

Author: Kow | Date: 2011

download study

Intermittent Vagal Blocking with an Implantable Device Reduces Maximum Tolerated Volume (MTV) During a Standardized Nutrient Drink Test in Obese Subjects

Publisher: Obes Surg. 2009;19(8):1012.

Author: Herrera | Date: 2009

download study

Selection of Electrical Algorithms to Treat Obesity with Intermittent Vagal Block Using an Implantable Medical Device

Publisher: Surg Obes Relat Dis. 2009;5(2):224-230.

Author: Camilleri | Date: 2009

download study

Intra-abdominal Vagal Blocking (VBLOC Therapy): Clinical Results with a New Implantable Medical Device

Publisher: Surgery. 2008;143:723-731.

Author: Camilleri | Date: 2008

download study